Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Sempra Energy (SRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Sempra Energy — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Sempra Energy trades at $80.08 (market cap $52.11B). The key difference: Sempra Energy is far larger — about 30.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Sempra Energy pays a 3.3% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Sempra Energy for 8 Days on average.
| NUVB | SRE | |
|---|---|---|
Market Cap | $1.71B | $52.11B |
Volume | 5,448,712 | 2,494,233 |
Sector | Health | Utilities |
52-Week High | $9.54 | $99.75 |
52-Week Low | $3.41 | $76.90 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $1.30B | $88.75B |
Dividend Yield | — | 3.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Sempra Energy
Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →
